Agilent Technologies, Inc. (a)
A — Company Overview
Investors tracking A follow a Diagnostics & Research name listed on NYQ within Healthcare.
| Ticker | A |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Exchange | NYQ |
| Market cap | $46.61B |
| Last price | $165.32 |
| Size category | Large Cap |
A — Business Description
The business profile of Agilent Technologies, Inc. (A) reflects its role in Diagnostics & Research. Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates through three segments: Life Sciences and Diagnostics Markets, Agilent CrossLab, and Applied Markets. The Life Sciences and Diagnostics Markets segment offers liquid chromatography systems and components; and liquid chromatography mass spectrometry systems. This segment is also involved in the genomics, contract development and manufacturing organization, pathology, companion diagnostics, and biomolecular analysis businesses. The Agilent CrossLab segment provides various services, including repairs, parts, maintenance, installations, training, complia…
Official website: https://www.agilent.com.
A — Investment Thesis
Agilent Technologies, Inc. (A) attracts investors weighing Diagnostics & Research fundamentals against current market pricing.
- Revenue is expanding at roughly 8.1% year-over-year (public data).
- Trailing P/E of 33.00× sits in a moderate band relative to high-growth peers.
- Forward P/E (24.47×) is below trailing P/E — earnings may be expected to improve.
- Dividend yield near 0.6% adds an income component to total return.
- Equity market capitalization is approximately $46.61B.
See the free estimates and earnings pages for public targets and growth metrics. Ownership, live news, and deeper models remain in Vest Terminal.
A — Financial Health
A financial profile reflects operating efficiency and capital structure using available market fundamentals.
Profit margin of 19.5% indicates solid bottom-line conversion. Positive free cash flow of $1.06B supports balance-sheet flexibility.
| Trailing P/E | 33.00× |
| Forward P/E | 24.47× |
| Price / Sales | 6.32× |
| Price / Book | 6.33× |
| Gross margin | 53.6% |
| Operating margin | 25.6% |
| Profit margin | 19.5% |
| Return on equity | 21.0% |
| Debt / Equity | 56.34 |
| Free cash flow | $1.06B |
A — Growth Outlook
Growth outlook for Agilent Technologies, Inc. (A) depends on demand trends in Diagnostics & Research and the company's ability to convert revenue into sustainable earnings.
- Revenue growth of 8.1% suggests steady but measured expansion.
- Earnings growth of 8.5% year-over-year supports improving profitability.
- Price is 2.1% below the 52-week high.
A — Competitive Position
Agilent Technologies, Inc. (A) is evaluated against peers on scale, margin structure, and capital efficiency within Healthcare.
- Competes within Healthcare, specifically in Diagnostics & Research.
- Market capitalization of $46.61B places A among large-cap peers.
- Gross margin near 53.6% may reflect pricing power or favorable mix.
A — Strengths
Strengths for Agilent Technologies, Inc. (A) inferred from public financial metrics:
- Revenue growth of 8.1% year-over-year.
- Earnings growth of 8.5% year-over-year.
- Return on equity near 21.0% — efficient use of shareholder capital.
- Gross margin of 53.6% supports competitive unit economics.
- Positive free cash flow ($1.06B).
- Moderate leverage (debt/equity 56.34).
A — Weaknesses
Weaknesses and pressure points for Agilent Technologies, Inc. (A) based on available data:
Insufficient public data to assess this factor.
A — Opportunities
- Sustained revenue growth (8.1%) could support multiple expansion if margins hold.
- Positive free cash flow enables reinvestment, debt reduction, or shareholder returns.
- Forward earnings multiple below trailing P/E — potential earnings acceleration ahead.
A — Risks
- Standard market, regulatory, competitive, and execution risks apply to all public equities.
A — Summary
Agilent Technologies, Inc. (A) is a large-cap Healthcare company focused on Diagnostics & Research, listed on NYQ. Last price $165.32 with market cap $46.61B. Trailing P/E 33.00×. Revenue grew 8.1% year-over-year per public data. Notable strengths include revenue growth of 8.1% year-over-year. Review free estimates and earnings pages for A; upgrade for institutional ownership and live headlines.
Start Free — open A in Vest Terminal
Access live data, filings, ownership, and analysis for Agilent Technologies, Inc..
Agilent Technologies, Inc. FAQ
What does Agilent Technologies, Inc. (A) do?
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates through three segments: Life Sciences and Diagnostics Markets, Agilent CrossLab, and Applied Markets. The Life Scienc…
What is A's P/E ratio?
Agilent Technologies, Inc. has a trailing P/E of 33.00× based on publicly available market data.
Does A pay a dividend?
Indicated dividend yield: 0.6%. Confirm ex-dates and payout history in Vest Terminal.
What sector is A in?
Agilent Technologies, Inc. is classified in Healthcare (Diagnostics & Research) on NYQ.
What is A's market capitalization?
Approximate market cap: $46.61B.
What are the main risks for A?
Key risks include above-average volatility (beta 1.24), among factors on this page.
What are the strengths of A?
Potential positives include revenue growth of 8.1% year-over-year, earnings growth of 8.5% year-over-year.
Where can I get analyst estimates for A?
Public analyst price targets and consensus for Agilent Technologies, Inc. are on the free /stocks/a/estimates page. Deeper estimate history and models are available in Vest Terminal.